666 (Trospium Container 60s)
Trospium Chloride Tablet
Product Images NDC 33342-554
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 33342-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig1 (Trospium Fig1)
This text appears to be a data table showing plasma concentration levels in ng/mL at different time points (hours post-dose). The time points are listed on top from 0 to 48 hours, with concentration levels likely measured at each specific time point.*
Fig2 (Trospium Fig2)
This is a comparison of the mean change in a certain variable between a placebo group (N=236) and a group taking trospium chloride tablets (N=253). The statistical significance of the difference is indicated by p<0.001 for both comparisons. The evaluation was done over the course of a treatment week.*
Fig3 (Trospium Fig3)
Fig4 (Trospium Fig4)
Fig5 (Trospium Fig5)
This text presents data on the mean change in response to placebo versus trospium chloride tablets over the course of treatment weeks. The results indicate statistically significant differences between the two groups, with p-values less than 0.001.*
Str (Trospium Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
